BioAtla (BCAB) Other Non Operating Income (2020 - 2026)

BioAtla's (BCAB) quarterly Other Non Operating Income came in at $3.0 million in Q1 2026, up 30.0% year-on-year from $2.3 million in Q1 2025, and up 660.3% quarter-over-quarter from -$529000.0 in Q4 2025.

BioAtla (BCAB) Other Non Operating Income (2020 - 2026) Analysis & Trends

BioAtla's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 30.0% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $382000.0, a 92.69% decrease from a year earlier, with the FY2025 full-year figure at -$302000.0, down 107.25% from the prior year.
  • Other Non Operating Income improved to $3.0 million in Q1 2026 per BCAB's latest filing, from -$529000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $3.0 million in Q1 2026 and bottomed at -$2.0 million in Q3 2025.
  • The 5-year median for Other Non Operating Income is $1.0 million (2022), against an average of $865411.8.
  • Across the five-year window, Other Non Operating Income soared 1497.83% in 2023 and sank 390.79% in 2025, its largest moves.
  • Year by year, Other Non Operating Income stood at $1.0 million in 2022, then soared by 58.41% to $1.6 million in 2023, then dropped by 15.58% to $1.4 million in 2024, then slumped by 138.9% to -$529000.0 in 2025, then soared by 660.3% to $3.0 million in 2026.
  • Per Business Quant, the three latest BCAB Other Non Operating Income figures stand at $3.0 million (Q1 2026), -$529000.0 (Q4 2025), and -$2.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 BioAtla 5.08 Mn 5.08 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.96 Mn
Dec 31, 2025 -529,000.00
Sep 30, 2025 -1.99 Mn
Jun 30, 2025 -64,000.00
Mar 31, 2025 2.28 Mn
Dec 31, 2024 1.36 Mn
Sep 30, 2024 684,000.00
Jun 30, 2024 900,000.00
Mar 31, 2024 1.22 Mn
Dec 31, 2023 1.61 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 1.45 Mn
Mar 31, 2023 1.47 Mn
Dec 31, 2022 1.02 Mn
Sep 30, 2022 400,000.00
Jun 30, 2022 149,000.00
Mar 31, 2022 92,000.00
Sep 30, 2021 765,000.00
Jun 30, 2021 79,000.00
Mar 31, 2021 96,000.00